Becton, Dickinson and Company (NYSE:BDX), a leading player in the medical technology sector with a market capitalization of ...

Company will spotlight sustainable solutions to enhance patient safety, workforce well-being, and care delivery efficiency ...

In a notable performance, Becton Dickinson and Co. (NYSE:BDX) stock achieved a 52-week high, reaching a price level of ...

Becton, Dickinson and Co. (BD) is investing in its U.S. manufacturing network to add capacity for critical medical devices, ...

BD (NYSE: BDX) announced today that it plans to invest further in U.S. manufacturing to add capacity for certain critical ...

Becton, Dickinson and Co. is increasing its U.S. manufacturing capacity for essential medical devices, including syringes, needles and IV catheters.

Overall, BD is expected to increase its production of domestically manufactured safety-engineered injection devices by more than 40% and conventional syringes by more than 50%. The manufacturer has ...

Barclays analyst Matt Miksic lowered the firm’s price target on Becton Dickinson (BDX) to $278 from $312 and keeps an Overweight rating on the ...

Franklin Lakes, New Jersey-based Becton, Dickinson and Company (BDX) develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products. With a market cap ...

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science ...

Becton Dickinson (BDX) announced additional investments in its U.S. manufacturing network to add capacity for medical devices, including ...

The results of the 2024-25 academic year medical college admission test have been published, with 5,372 candidates selected ...